Skip to main content
. 2021 Apr 15;10(8):1694. doi: 10.3390/jcm10081694
CI confidence interval
DAA direct-acting antivirals
HCC hepatocellular carcinoma
HCV hepatitis C virus
PEG-IFN pegylated interferon
PRISMA Preferred Reporting Items for Systematic Review and Meta-analysis
SVR sustained virological response